<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03390426</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00089161</org_study_id>
    <nct_id>NCT03390426</nct_id>
  </id_info>
  <brief_title>Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension</brief_title>
  <official_title>Femoral Peri-arterial Local Anesthetic Injection Decreases Tourniquet Associated Ischemic Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective randomized double-blind study is to determine if the novel
      technique of ultrasound guided peri-arterial injection of local anesthetic around the femoral
      artery decreases ischemic hypertension associated with prolonged lower extremity tourniquet
      time during total ankle arthroplasty (TAA) and foot fusion surgeries. Patients will be
      randomized 1:1 to receive either local anesthetic or saline, which will be injected
      superomedially to the femoral artery in an attempt to block sympathetic afferents and
      decrease tourniquet associated hypertension intraoperatively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective randomized double-blind study is to determine if the novel
      technique of ultrasound guided peri-arterial injection of local anesthetic around the femoral
      artery decreases ischemic hypertension associated with prolonged lower extremity tourniquet
      time during total ankle arthroplasty (TAA) and foot fusion surgeries. Efficacy will be
      determined by analyzing incidence of intraoperative ischemic hypertension, defined as &gt;30%
      increase in systolic blood pressure, associated with tourniquet inflation times greater than
      90 minutes. The study will involve a total of 30 patients (15 in each group) and with a power
      of 80% to detect a 50% difference. The patients involved in the study will be ASA 1-3
      patients who are undergoing either TAA or foot fusion surgeries. Patients will receive
      standard of care for their anesthesia, which at Duke Hospital includes placement of popliteal
      and saphenous perineural catheters and a general anesthetic with a laryngeal mask airway.
      Patients will be randomized to receive femoral peri-arterial injection with either 1.5%
      mepivacaine with 1:400,000 epinephrine or 0.9% saline which will be performed preoperatively
      at time of perineural catheter placement. Patients will assume standard risk associated with
      nerve blocks, including theoretical risk of nerve damage and local anesthetic systemic
      toxicity. Possible benefits include improved intraoperative hemodynamic stability, decreased
      intraoperative opioid and antihypertensive medications, and decreased tourniquet associated
      pain post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 3, 2018</start_date>
  <completion_date type="Actual">October 28, 2018</completion_date>
  <primary_completion_date type="Actual">October 27, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects Experiencing Tourniquet Hypertension</measure>
    <time_frame>Intraoperatively (~3 hours)</time_frame>
    <description>Measuring systolic blood pressure using a cuff, aim to keep &lt;30mmHg change from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores as Measured by the Numeric Rating Scale (NRS-11)</measure>
    <time_frame>While in PACU (~1 hour)</time_frame>
    <description>The NRS-11 is an 11-point scale for patient self-reporting of pain. 0 = No Pain, 1-3 = Mild Pain, 4-6 = Moderate Pain, 7-10 = Severe Pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Opioid Pain Medications Used by Patient</measure>
    <time_frame>Perioperative period (~4 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Esmolol Used Intraoperatively</measure>
    <time_frame>Intraoperatively (~3 hours)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Tourniquet Hypertension</condition>
  <condition>Intraoperative Hypertension</condition>
  <condition>Total Ankle Arthroplasty</condition>
  <condition>Ankle Fusion</condition>
  <arm_group>
    <arm_group_label>Mepivacaine Block Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline Sham Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Injection of salt water (saline) above and beside the femoral artery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivacaine</intervention_name>
    <description>An ultrasound guided injection of mepivacaine superomedially to the femoral artery.</description>
    <arm_group_label>Mepivacaine Block Group</arm_group_label>
    <other_name>Carbocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Perifemoral Injection of Local Anesthetic</intervention_name>
    <description>An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
    <arm_group_label>Mepivacaine Block Group</arm_group_label>
    <arm_group_label>Saline Sham Group</arm_group_label>
    <other_name>Femoral periarterial injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
    <arm_group_label>Saline Sham Group</arm_group_label>
    <other_name>Salt Water placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients that will be included in the study are English speaking 18-75 year old ASA 1-3
        patients undergoing total ankle arthroplasty.

        Exclusion Criteria:

          1. ASA 4 or 5

          2. Diagnosis of chronic pain

          3. Daily chronic opioid use (over 3 months of continuous opioid use).

          4. Inability to communicate pain scores or need for analgesia.

          5. Infection at the site of block placement

          6. Age under 18 years old or greater than 75 years old

          7. Pregnant women (as determined by standard of care day-of surgery urine bHCG)

          8. Intolerance/allergy to local anesthetics

          9. Weight &lt;50 kg

         10. Suspected, or known addiction to or abuse of illicit drug(s), prescription
             medicine(s), or alcohol within the past 2 years.

         11. Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the
             opinion of the investigator, may interfere with study assessments or compliance.

         12. Current or historical evidence of any clinically significant disease or condition
             that, in the opinion of the investigator, may increase the risk of surgery or
             complicate the subject's postoperative course
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William M Bullock</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>December 28, 2017</study_first_submitted>
  <study_first_submitted_qc>December 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 4, 2018</study_first_posted>
  <results_first_submitted>October 8, 2019</results_first_submitted>
  <results_first_submitted_qc>October 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 30, 2019</results_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Perifemoral</keyword>
  <keyword>Tourniquet</keyword>
  <keyword>Mepivacaine</keyword>
  <keyword>Tourniquet Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be shared; patients will be deidentified and no personal information or medical records used.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/26/NCT03390426/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mepivacaine Block Group</title>
          <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
        </group>
        <group group_id="P2">
          <title>Saline Sham Group</title>
          <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Subjects who completed the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Mepivacaine Block Group</title>
          <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
        </group>
        <group group_id="B2">
          <title>Saline Sham Group</title>
          <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.47" spread="11.84"/>
                    <measurement group_id="B2" value="65.67" spread="4.61"/>
                    <measurement group_id="B3" value="63.81" spread="9.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA Status</title>
          <description>American Society of Anesthesiologists (ASA) Physical Status Classification. ASA 1 = a normal healthy patient, ASA 2 = a patient with mild systemic disease, ASA 3 = a patient with severe systemic disease.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>ASA 1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA 2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA 3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.11" spread="4.63"/>
                    <measurement group_id="B2" value="32.64" spread="5.41"/>
                    <measurement group_id="B3" value="31.63" spread="5.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects Experiencing Tourniquet Hypertension</title>
        <description>Measuring systolic blood pressure using a cuff, aim to keep &lt;30mmHg change from baseline</description>
        <time_frame>Intraoperatively (~3 hours)</time_frame>
        <population>Subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Mepivacaine Block Group</title>
            <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Saline Sham Group</title>
            <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Experiencing Tourniquet Hypertension</title>
          <description>Measuring systolic blood pressure using a cuff, aim to keep &lt;30mmHg change from baseline</description>
          <population>Subjects who completed the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Scores as Measured by the Numeric Rating Scale (NRS-11)</title>
        <description>The NRS-11 is an 11-point scale for patient self-reporting of pain. 0 = No Pain, 1-3 = Mild Pain, 4-6 = Moderate Pain, 7-10 = Severe Pain.</description>
        <time_frame>While in PACU (~1 hour)</time_frame>
        <population>Subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Mepivacaine Block Group</title>
            <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Saline Sham Group</title>
            <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scores as Measured by the Numeric Rating Scale (NRS-11)</title>
          <description>The NRS-11 is an 11-point scale for patient self-reporting of pain. 0 = No Pain, 1-3 = Mild Pain, 4-6 = Moderate Pain, 7-10 = Severe Pain.</description>
          <population>Subjects who completed the study.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.80" spread="2.86"/>
                    <measurement group_id="O2" value="1.07" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Opioid Pain Medications Used by Patient</title>
        <time_frame>Perioperative period (~4 hours)</time_frame>
        <population>Subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Mepivacaine Block Group</title>
            <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Saline Sham Group</title>
            <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Opioid Pain Medications Used by Patient</title>
          <population>Subjects who completed the study.</population>
          <units>morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.48" spread="5.77"/>
                    <measurement group_id="O2" value="8.19" spread="4.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Esmolol Used Intraoperatively</title>
        <time_frame>Intraoperatively (~3 hours)</time_frame>
        <population>Subjects who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Mepivacaine Block Group</title>
            <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
          </group>
          <group group_id="O2">
            <title>Saline Sham Group</title>
            <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Esmolol Used Intraoperatively</title>
          <population>Subjects who completed the study.</population>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.00" spread="14.24"/>
                    <measurement group_id="O2" value="95.33" spread="107.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Mepivacaine Block Group</title>
          <description>Injection of local anesthetic (mepivacaine) above and beside the femoral artery.
Mepivacaine: An ultrasound guided injection of mepivacaine superomedially to the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.</description>
        </group>
        <group group_id="E2">
          <title>Saline Sham Group</title>
          <description>Injection of salt water (saline) above and beside the femoral artery.
Perifemoral Injection of Local Anesthetic: An ultrasound guided injection of mepivacaine superomedially to the formal artery in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Saline: An ultrasound guided injection using a medication that does NOT numb any nerves called saline, or salt water.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>William Michael Bullock, MD, PhD</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>919-681-6437</phone>
      <email>william.bullock@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

